Jonathan D. Picker, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fragile X Syndrome | 6 | 2017 | 116 | 1.300 |
Why?
|
| Fluvoxamine | 1 | 2022 | 78 | 0.800 |
Why?
|
| Developmental Disabilities | 8 | 2018 | 1509 | 0.720 |
Why?
|
| Rett Syndrome | 3 | 2013 | 163 | 0.680 |
Why?
|
| Homocystinuria | 2 | 2019 | 64 | 0.680 |
Why?
|
| Muscle Hypotonia | 2 | 2017 | 161 | 0.520 |
Why?
|
| Sudden Infant Death | 1 | 2018 | 292 | 0.500 |
Why?
|
| Drugs, Investigational | 1 | 2017 | 212 | 0.490 |
Why?
|
| Desmin | 1 | 2013 | 99 | 0.440 |
Why?
|
| Phenotype | 16 | 2022 | 16572 | 0.380 |
Why?
|
| Mutation | 16 | 2021 | 30015 | 0.370 |
Why?
|
| Muscular Dystrophies | 1 | 2013 | 390 | 0.360 |
Why?
|
| Pedigree | 8 | 2021 | 4539 | 0.330 |
Why?
|
| Gene Deletion | 3 | 2018 | 2659 | 0.320 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2007 | 183 | 0.300 |
Why?
|
| Genetic Testing | 7 | 2019 | 3533 | 0.300 |
Why?
|
| Heterozygote | 4 | 2016 | 2780 | 0.280 |
Why?
|
| Tuberous Sclerosis | 1 | 2013 | 1031 | 0.250 |
Why?
|
| Genetic Association Studies | 5 | 2019 | 2734 | 0.240 |
Why?
|
| Autistic Disorder | 4 | 2016 | 1219 | 0.240 |
Why?
|
| Tourette Syndrome | 1 | 2008 | 395 | 0.240 |
Why?
|
| Abnormalities, Multiple | 5 | 2018 | 1422 | 0.230 |
Why?
|
| Chromosome Aberrations | 5 | 2014 | 1768 | 0.230 |
Why?
|
| Anxiety | 1 | 2019 | 4573 | 0.220 |
Why?
|
| Behavior, Animal | 3 | 2012 | 1872 | 0.220 |
Why?
|
| Hyperargininemia | 1 | 2003 | 12 | 0.220 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2018 | 1074 | 0.210 |
Why?
|
| Spasms, Infantile | 2 | 2021 | 298 | 0.210 |
Why?
|
| Genomics | 1 | 2018 | 5822 | 0.200 |
Why?
|
| Homocysteine | 1 | 2005 | 637 | 0.200 |
Why?
|
| Mutation, Missense | 4 | 2021 | 2570 | 0.200 |
Why?
|
| CHARGE Syndrome | 2 | 2012 | 34 | 0.190 |
Why?
|
| Epilepsies, Partial | 2 | 2018 | 431 | 0.190 |
Why?
|
| Cardiomyopathies | 1 | 2013 | 1948 | 0.190 |
Why?
|
| Fetal Diseases | 2 | 2012 | 913 | 0.190 |
Why?
|
| Glutamate Carboxypeptidase II | 2 | 2012 | 82 | 0.180 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2669 | 0.180 |
Why?
|
| Glutamine | 1 | 2003 | 576 | 0.170 |
Why?
|
| Heterochromatin | 1 | 2002 | 291 | 0.170 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2019 | 21 | 0.160 |
Why?
|
| Mosaicism | 2 | 2021 | 474 | 0.160 |
Why?
|
| Syndrome | 5 | 2018 | 3268 | 0.160 |
Why?
|
| Depression | 1 | 2019 | 8132 | 0.160 |
Why?
|
| Mental Disorders | 1 | 2019 | 6826 | 0.160 |
Why?
|
| Hexokinase | 1 | 2019 | 124 | 0.160 |
Why?
|
| Brain Edema | 1 | 2003 | 604 | 0.150 |
Why?
|
| Folic Acid | 1 | 2005 | 1323 | 0.150 |
Why?
|
| Child | 26 | 2021 | 80089 | 0.150 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2019 | 89 | 0.150 |
Why?
|
| Germ-Line Mutation | 3 | 2022 | 1852 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2019 | 17878 | 0.150 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2018 | 47 | 0.150 |
Why?
|
| Chromosome Disorders | 2 | 2012 | 497 | 0.150 |
Why?
|
| HLA-A Antigens | 1 | 2018 | 223 | 0.150 |
Why?
|
| Ubiquitination | 1 | 2022 | 1006 | 0.140 |
Why?
|
| Infant | 17 | 2021 | 36157 | 0.140 |
Why?
|
| Epilepsy, Generalized | 1 | 2019 | 178 | 0.140 |
Why?
|
| Child, Preschool | 17 | 2021 | 42193 | 0.140 |
Why?
|
| Myokymia | 1 | 2015 | 11 | 0.130 |
Why?
|
| Ataxia | 2 | 2015 | 306 | 0.130 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2015 | 30 | 0.130 |
Why?
|
| Craniofacial Abnormalities | 1 | 2018 | 319 | 0.130 |
Why?
|
| Obesity Hypoventilation Syndrome | 1 | 2015 | 17 | 0.120 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 517 | 0.120 |
Why?
|
| De Lange Syndrome | 1 | 2015 | 21 | 0.120 |
Why?
|
| GTPase-Activating Proteins | 1 | 2018 | 471 | 0.120 |
Why?
|
| Cataplexy | 1 | 2015 | 61 | 0.120 |
Why?
|
| Mitochondrial Diseases | 1 | 2018 | 343 | 0.120 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 141 | 0.120 |
Why?
|
| Genotype | 4 | 2019 | 12977 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2008 | 4937 | 0.120 |
Why?
|
| Mothers | 1 | 2005 | 2194 | 0.120 |
Why?
|
| Autopsy | 1 | 2018 | 1008 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2016 | 343 | 0.120 |
Why?
|
| Sequence Alignment | 2 | 2021 | 2178 | 0.110 |
Why?
|
| Hypothalamic Diseases | 1 | 2015 | 134 | 0.110 |
Why?
|
| Neonatal Screening | 2 | 2012 | 597 | 0.110 |
Why?
|
| Genes, Recessive | 1 | 2016 | 623 | 0.110 |
Why?
|
| Schizophrenia | 3 | 2016 | 6929 | 0.110 |
Why?
|
| Humans | 48 | 2022 | 760740 | 0.110 |
Why?
|
| Comparative Genomic Hybridization | 4 | 2016 | 473 | 0.110 |
Why?
|
| Exons | 3 | 2009 | 2381 | 0.110 |
Why?
|
| Receptors, GABA-A | 1 | 2017 | 622 | 0.100 |
Why?
|
| Genomic Library | 1 | 2012 | 189 | 0.100 |
Why?
|
| DNA Copy Number Variations | 4 | 2018 | 2020 | 0.100 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 974 | 0.100 |
Why?
|
| Phospholipase C beta | 1 | 2012 | 49 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2018 | 1336 | 0.100 |
Why?
|
| Female | 35 | 2021 | 392203 | 0.100 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 5789 | 0.100 |
Why?
|
| Male | 35 | 2021 | 360402 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2018 | 944 | 0.100 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 269 | 0.100 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2016 | 243 | 0.100 |
Why?
|
| Anticonvulsants | 2 | 2021 | 1910 | 0.100 |
Why?
|
| Inheritance Patterns | 2 | 2018 | 341 | 0.100 |
Why?
|
| Facies | 3 | 2018 | 222 | 0.100 |
Why?
|
| Folic Acid Deficiency | 1 | 2012 | 117 | 0.090 |
Why?
|
| Microarray Analysis | 2 | 2011 | 748 | 0.090 |
Why?
|
| Genetic Variation | 2 | 2019 | 6561 | 0.090 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2011 | 600 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2008 | 7847 | 0.090 |
Why?
|
| Maze Learning | 1 | 2012 | 482 | 0.090 |
Why?
|
| Brain Waves | 1 | 2014 | 409 | 0.090 |
Why?
|
| Adolescent | 16 | 2021 | 88247 | 0.090 |
Why?
|
| Heart Defects, Congenital | 3 | 2014 | 4671 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2011 | 313 | 0.090 |
Why?
|
| Puberty, Delayed | 1 | 2010 | 121 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 725 | 0.080 |
Why?
|
| Karyotyping | 3 | 2011 | 1171 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2019 | 2410 | 0.080 |
Why?
|
| Infant, Newborn | 7 | 2019 | 26183 | 0.080 |
Why?
|
| Trisomy | 2 | 2010 | 260 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 11874 | 0.070 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 1433 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 4739 | 0.070 |
Why?
|
| DNA Mutational Analysis | 4 | 2018 | 4110 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2013 | 831 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2008 | 346 | 0.070 |
Why?
|
| Computational Biology | 1 | 2019 | 3509 | 0.070 |
Why?
|
| Condiments | 1 | 1986 | 7 | 0.070 |
Why?
|
| Gene Duplication | 1 | 2008 | 314 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2018 | 12116 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3776 | 0.070 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 2112 | 0.070 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2008 | 263 | 0.070 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2016 | 1473 | 0.070 |
Why?
|
| Adult | 13 | 2021 | 220995 | 0.060 |
Why?
|
| Congenital Abnormalities | 1 | 2011 | 709 | 0.060 |
Why?
|
| Haploinsufficiency | 2 | 2022 | 336 | 0.060 |
Why?
|
| Vocalization, Animal | 1 | 2006 | 94 | 0.060 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2005 | 46 | 0.060 |
Why?
|
| Prenatal Diagnosis | 1 | 2012 | 1265 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2022 | 1894 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 2518 | 0.060 |
Why?
|
| DNA Helicases | 1 | 2010 | 851 | 0.060 |
Why?
|
| Alleles | 4 | 2019 | 6861 | 0.060 |
Why?
|
| Brain | 3 | 2016 | 27100 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2005 | 192 | 0.060 |
Why?
|
| Hyperhomocysteinemia | 1 | 2005 | 118 | 0.060 |
Why?
|
| Carcinogens | 1 | 1986 | 452 | 0.060 |
Why?
|
| Reflex | 1 | 2006 | 375 | 0.060 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2005 | 174 | 0.060 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2005 | 276 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 1276 | 0.060 |
Why?
|
| Animals | 9 | 2022 | 168202 | 0.060 |
Why?
|
| Mouth Mucosa | 1 | 1986 | 432 | 0.060 |
Why?
|
| Amino Acids, Basic | 1 | 2003 | 9 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 3447 | 0.050 |
Why?
|
| Hand Strength | 1 | 2006 | 456 | 0.050 |
Why?
|
| Arginase | 1 | 2003 | 78 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2005 | 582 | 0.050 |
Why?
|
| Acyl-CoA Dehydrogenases | 1 | 2002 | 24 | 0.050 |
Why?
|
| Family | 1 | 2013 | 3193 | 0.050 |
Why?
|
| Base Sequence | 1 | 2013 | 12420 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15829 | 0.050 |
Why?
|
| Ammonia | 1 | 2003 | 237 | 0.050 |
Why?
|
| Munc18 Proteins | 1 | 2021 | 20 | 0.050 |
Why?
|
| Seizures | 1 | 2014 | 2964 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2021 | 3601 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 7995 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18220 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2008 | 2509 | 0.050 |
Why?
|
| Psychotic Disorders | 1 | 2016 | 3220 | 0.040 |
Why?
|
| Young Adult | 5 | 2019 | 59191 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2021 | 12759 | 0.040 |
Why?
|
| Arginine | 1 | 2003 | 933 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 3634 | 0.040 |
Why?
|
| Movement | 1 | 2006 | 1476 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 13442 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2012 | 14388 | 0.040 |
Why?
|
| Ceftriaxone | 1 | 2019 | 175 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 634 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2012 | 3979 | 0.040 |
Why?
|
| Dynamins | 1 | 2018 | 139 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2005 | 1140 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6188 | 0.030 |
Why?
|
| DNA | 1 | 2010 | 7196 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2021 | 898 | 0.030 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2002 | 589 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2011 | 1490 | 0.030 |
Why?
|
| Speech Disorders | 1 | 2017 | 180 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2018 | 816 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 1229 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2002 | 2601 | 0.030 |
Why?
|
| Cell Line | 2 | 2021 | 15577 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 2016 | 122 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 1320 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2006 | 2637 | 0.030 |
Why?
|
| Mice | 6 | 2022 | 81368 | 0.030 |
Why?
|
| Retinitis Pigmentosa | 1 | 2019 | 397 | 0.030 |
Why?
|
| Body Weight | 1 | 2006 | 4615 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2021 | 1594 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2019 | 80583 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 1878 | 0.030 |
Why?
|
| Pregnancy | 3 | 2018 | 29869 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2003 | 1795 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 9586 | 0.030 |
Why?
|
| Movement Disorders | 1 | 2017 | 459 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 2016 | 463 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2012 | 63 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2012 | 115 | 0.020 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2012 | 107 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 733 | 0.020 |
Why?
|
| Trinucleotide Repeats | 1 | 2012 | 257 | 0.020 |
Why?
|
| Tremor | 1 | 2012 | 190 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 1386 | 0.020 |
Why?
|
| Epilepsy | 2 | 2017 | 3303 | 0.020 |
Why?
|
| Chromosome Duplication | 1 | 2011 | 75 | 0.020 |
Why?
|
| Genome, Human | 2 | 2015 | 4421 | 0.020 |
Why?
|
| Allelic Imbalance | 1 | 2011 | 77 | 0.020 |
Why?
|
| Motor Activity | 2 | 2012 | 2714 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 64572 | 0.020 |
Why?
|
| Uniparental Disomy | 1 | 2010 | 45 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4269 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 12966 | 0.020 |
Why?
|
| Sensory Gating | 1 | 2009 | 47 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 441 | 0.020 |
Why?
|
| Cerebellum | 1 | 2016 | 1501 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2010 | 193 | 0.020 |
Why?
|
| Motor Cortex | 1 | 2016 | 1007 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2010 | 453 | 0.020 |
Why?
|
| Diet | 1 | 1986 | 8049 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2009 | 195 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2012 | 1185 | 0.020 |
Why?
|
| Kidney | 1 | 2003 | 7044 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 1776 | 0.020 |
Why?
|
| Liver | 1 | 2003 | 7512 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1392 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 928 | 0.020 |
Why?
|
| Cheek | 1 | 1986 | 65 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 1301 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 4611 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2009 | 446 | 0.020 |
Why?
|
| Space Perception | 1 | 2009 | 465 | 0.020 |
Why?
|
| Social Behavior | 1 | 2012 | 1135 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1505 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2015 | 2851 | 0.020 |
Why?
|
| Boston | 1 | 2018 | 9313 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2009 | 1235 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 1754 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 1748 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2007 | 1692 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 6074 | 0.010 |
Why?
|
| Risk Factors | 2 | 2011 | 74128 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2012 | 3431 | 0.010 |
Why?
|
| Heart Murmurs | 1 | 2002 | 92 | 0.010 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2002 | 57 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2016 | 36401 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2009 | 1438 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2012 | 2515 | 0.010 |
Why?
|
| Disease Management | 1 | 2011 | 2506 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2015 | 41464 | 0.010 |
Why?
|
| India | 1 | 1986 | 2286 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 9526 | 0.010 |
Why?
|
| Memory | 1 | 2009 | 2192 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2012 | 3599 | 0.010 |
Why?
|
| Sex Factors | 1 | 2012 | 10549 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2014 | 6240 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15908 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22153 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1986 | 2894 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 3708 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 7569 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2002 | 2189 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 39908 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2002 | 1310 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 23415 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 220603 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 5776 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 20556 | 0.000 |
Why?
|